WDD

Know how to manage and prevent diabetes for a better life

Retrieved on: 
Tuesday, November 14, 2023
Well, Consensus, Chinese, World Diabetes Day, EASD, Consensus decision-making, Food, Chapter, Risk, American Diabetes Association, IDF, Patient, To Brazil!, ANAD, Sugar, WDD, Social media, Friends, International Diabetes Federation, Person, ISA, Family, Quality of life, Dietary supplement, Soft drink, Nutrition, Diabetes

Knowing your risk of type 2 diabetes to help delay or prevent the condition is important.

Key Points: 
  • Knowing your risk of type 2 diabetes to help delay or prevent the condition is important.
  • Alongside other cornerstones of diabetes management, a healthy diet has the potential to improve glucose control, reduce the risk of diabetes complications and improve quality of life.
  • More information about World Diabetes Day 2023 is available on the WDD website available at: https://worlddiabetesday.org
    IDF, Diabetes Atlas 10th edition 2021.
  • Consenso de la Asociación Latinoamericana de Diabetes sobre uso de edulcorantes no calóricos en personas con diabetes [Consensus of the Latin-American Association of Diabetes on low calorie sweeteners in persons with diabetes].

'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum

Retrieved on: 
Monday, November 6, 2023
Global Medical Device Nomenclature, Patient, Ulcer, Education, PN, Prickle (protein), Neuropathic pain, Neurology, Assistant, Facial muscles, Physician, Prevalence, IDF, Burning Sensations, Health, International Diabetes Federation, DPN, Type 2 diabetes, WDD, Finger, Foot, Hypoesthesia, Senior, AMA, Prediabetes, Paresthesia, Quality of life, Bethesda Hospital, The, Extremities, Risk, P&G, Peripheral neuropathy, Lyceum, Trial of the century, B, Pharmacist, Ankle, Amputation, Diagnosis, Consultant, Infection, Dietary supplement, Pharmaceutical industry, Diabetes

The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.

Key Points: 
  • The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.
  • With Diabetes Mellitus Type 2 being the leading cause of PN, its increasing prevalence is closely linked to the rise in the number of diabetics.
  • B vitamin deficiency and polymedication are other high-risk factors along with diabetes, leading to peripheral nerve damage.
  • Patients should be educated about the importance of regular foot and DPN examinations, glycemic control, and adherence to prescribed medications.

Promote education on diabetes for a healthier tomorrow

Retrieved on: 
Monday, November 14, 2022
Obesity, Education, Systematic review, European Food Safety Authority, Friends, International Diabetes Federation, Meta-analysis, Federalisation of the European Union, Raben Group, WDD, Social media, Health care, ISA, Diabetes, EFAD, Pleasure, Safety, Disease, Sugar, American Journal, IDF, Family, EFSA, Risk, Carbohydrate, Anton Greyling, Pharmaceutical industry, Soft drink

One in two people with diabetes dont know they have the disease and remain undiagnosed.

Key Points: 
  • One in two people with diabetes dont know they have the disease and remain undiagnosed.
  • Education on low/no calorie sweeteners can help people living with diabetes: ISA campaign for WDD 2022
    Both health professionals and people living with diabetes need to have better access to nutrition education in diabetes, including about the role of low/no calorie sweeteners in diabetes control.
  • Share the ISA campaign for World Diabetes Day 2022 on social media with your friends, family and network by using the dedicated hashtags #ISA4WDD, #WDD2022 and #EducationToProtect.
  • American Journal of Clinical Nutrition 2020; 112(4): 1002-1014
    EFSA Scientific opinion on the substantiation of health claims related to intense sweeteners.

FDAnews Announces: FDA's New Distributor Licensing Standards Webinar on May 18, 2022

Retrieved on: 
Wednesday, May 4, 2022
Policy, FDA, Compliance, Wisconsin Independent News Distributors, WDD, DSCSA, Dangerous Drugs (Supply to Addicts) Regulations 1968, Arnold & Porter, 3PL, Organization, Review, Drug Quality and Security Act, United States Congress Office of Compliance, Arnold, Pharmaceutical industry, Medical device

FALLS CHURCH, Va., May 4, 2022 /PRNewswire-PRWeb/ -- FDA's New Distributor Licensing Standards: What Manufacturers, Wholesale Distributors and Third-Party Logistics Providers Must Know An FDAnews Webinar Wednesday, May 18, 2022, 1:30 p.m.–3:00 p.m. EDT https://wcg.swoogo.com/fdas-new-distributor-licensing-standards

Key Points: 
  • Drugmakers need to be ready when the U.S. domestic prescription drug distribution is upended.
  • The FDA's recent 50-page proposed rule may do just that when finalized, forcing manufacturers to adapt their processes to a whole new set of requirements.
  • This webinar, with a former senior FDA official, is the solution.
  • FDA's New Distributor Licensing Standards:

World Diabetes Day and American Diabetes Month: Echosens Highlights Link Between Diabetes and Liver Disease, Urges Non-Invasive Detection and Monitoring

Retrieved on: 
Monday, November 15, 2021
Biotechnology, Diabetes, Medical Devices, Health, Managed Care, Mortality, Population, Type 2 diabetes, News, WDD, Pioneer, Degenerative disease, Elastography, World, Obesity, Liver disease, Liver, Metabolic syndrome, Risk, NAFLD, Overweight, Fatty liver disease, Cardiovascular disease, Global health, Metadata, World Diabetes Day, Publication, Diagnosis, Prediabetes, Weight loss, Diabetes, Prevalence, Patient, Adult, American Diabetes Association, Statistics, Pharmaceutical industry

WWD, a three-year campaign to improve access to diabetes care and prevent diabetes, and the American Diabetes Month present opportunities to highlight how obesity increases the risk for Type 2 diabetes, liver disease, MetS and heart disease, says Dominique Legros, Echosens Group CEO.

Key Points: 
  • WWD, a three-year campaign to improve access to diabetes care and prevent diabetes, and the American Diabetes Month present opportunities to highlight how obesity increases the risk for Type 2 diabetes, liver disease, MetS and heart disease, says Dominique Legros, Echosens Group CEO.
  • Fat in the liver can increase the risks of progression of prediabetes to overt disease.
  • Once a patient has fatty liver disease, diabetes may become more difficult to control, making it critical to obtain an early diagnosis and introduce lifestyle changes to halt or reverse NAFLD.
  • Pioneer in its field, Echosens significantly changed the practice of liver assessment with FibroScan, the non-invasive solution for comprehensive management of liver health.